TRIGEN
Live / Applied — Extension of time to oppose received (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 30 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98674089
- Mark type
- Stylized text
- Filed
- 30 Jul 2024
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Neil C. Jones
Goods and services
- Class 005 — Pharmaceuticals: Full line of pharmaceutical products, namely pharmaceutical products and preparations for treating diseases and conditions in gynecology and women's health, pharmaceutical products and preparations for use as prenatal supplements, pharmaceutical products and preparations for use as iron supplements, pharmaceutical products and preparations for use as multivitamin and mineral supplements, vitamin supplements and nutraceuticals for use as dietary supplements, pharmaceutical products and preparations for treating symptoms associated with menopause, pharmaceutical products and preparations for treating menopause and post menopause symptoms and conditions, pharmaceutical products and preparations for use in pain management, pharmaceutical products and preparations for use as opioid analgesics, pharmaceutical products and preparations for treating musculoskeletal conditions, and pharmaceutical products and preparations for use as a centrally-acting agents for musculoskeletal conditions; pharmaceutical preparations for managing and relieving pain and inflammation, pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis, pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder, and pharmaceutical products and preparations for use as antidepressants
- Class 042 — Scientific and technological services: Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Generic pharmaceutical research and development
Owner
- Trigen Laboratories, LLC, Alpharetta, GA, US
- Trigen Laboratories, LLC, Alpharetta, GA, US
Prosecution history
- 07 Jan 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Nov 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 29 Aug 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 29 Aug 2025 — FINAL REFUSAL E-MAILED
- 29 Aug 2025 — FINAL REFUSAL WRITTEN
- 06 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED